Induction of mammalian stress proteins by a triethylphosphine gold compound used in the therapy of rheumatoid arthritis

Madelyn M. Caltabiano, Thomas P. Koestler, George Poste, Russell G. Greig

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In vitro exposure of cultured human, murine and rat cells to pharmacologic concentrations (10-8 to 10-6M) of auranofin, 2,3,4,6,-tetra-O-acetyl-1-thio-β-D-glucopyranosato-S-triethylphosphine gold(I) (RidauraTM), a gold containing compound approved for the treatment of rheumatoid arthritis, results in the induction of several stress proteins. The enhanced synthesis of two polypeptides, p32 and p34, was particularly prominent. A similar response was observed in freshly collected human monocytes challenged with auranofin. In addition, oral administration of auranofin to rats induced enhanced synthesis of a 32-kDa protein in peritoneal exudate cells analyzed ex vivo at various times following drug treatment. These data suggest that increased synthesis of p32 and p34 might participate in mediating certain aspects of auranofin pharmacology.

Original languageEnglish (US)
Pages (from-to)1074-1080
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume138
Issue number3
DOIs
StatePublished - Aug 14 1986
Externally publishedYes

Fingerprint

Gold Compounds
Auranofin
Heat-Shock Proteins
Rheumatoid Arthritis
Gold
Rats
Drug therapy
Exudates and Transudates
Therapeutics
Oral Administration
Monocytes
Pharmacology
Peptides
Pharmaceutical Preparations
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Induction of mammalian stress proteins by a triethylphosphine gold compound used in the therapy of rheumatoid arthritis. / Caltabiano, Madelyn M.; Koestler, Thomas P.; Poste, George; Greig, Russell G.

In: Biochemical and Biophysical Research Communications, Vol. 138, No. 3, 14.08.1986, p. 1074-1080.

Research output: Contribution to journalArticle

@article{1fc8b17b13d645a4a1d8f033ee860a17,
title = "Induction of mammalian stress proteins by a triethylphosphine gold compound used in the therapy of rheumatoid arthritis",
abstract = "In vitro exposure of cultured human, murine and rat cells to pharmacologic concentrations (10-8 to 10-6M) of auranofin, 2,3,4,6,-tetra-O-acetyl-1-thio-β-D-glucopyranosato-S-triethylphosphine gold(I) (RidauraTM), a gold containing compound approved for the treatment of rheumatoid arthritis, results in the induction of several stress proteins. The enhanced synthesis of two polypeptides, p32 and p34, was particularly prominent. A similar response was observed in freshly collected human monocytes challenged with auranofin. In addition, oral administration of auranofin to rats induced enhanced synthesis of a 32-kDa protein in peritoneal exudate cells analyzed ex vivo at various times following drug treatment. These data suggest that increased synthesis of p32 and p34 might participate in mediating certain aspects of auranofin pharmacology.",
author = "Caltabiano, {Madelyn M.} and Koestler, {Thomas P.} and George Poste and Greig, {Russell G.}",
year = "1986",
month = "8",
day = "14",
doi = "10.1016/S0006-291X(86)80391-6",
language = "English (US)",
volume = "138",
pages = "1074--1080",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Induction of mammalian stress proteins by a triethylphosphine gold compound used in the therapy of rheumatoid arthritis

AU - Caltabiano, Madelyn M.

AU - Koestler, Thomas P.

AU - Poste, George

AU - Greig, Russell G.

PY - 1986/8/14

Y1 - 1986/8/14

N2 - In vitro exposure of cultured human, murine and rat cells to pharmacologic concentrations (10-8 to 10-6M) of auranofin, 2,3,4,6,-tetra-O-acetyl-1-thio-β-D-glucopyranosato-S-triethylphosphine gold(I) (RidauraTM), a gold containing compound approved for the treatment of rheumatoid arthritis, results in the induction of several stress proteins. The enhanced synthesis of two polypeptides, p32 and p34, was particularly prominent. A similar response was observed in freshly collected human monocytes challenged with auranofin. In addition, oral administration of auranofin to rats induced enhanced synthesis of a 32-kDa protein in peritoneal exudate cells analyzed ex vivo at various times following drug treatment. These data suggest that increased synthesis of p32 and p34 might participate in mediating certain aspects of auranofin pharmacology.

AB - In vitro exposure of cultured human, murine and rat cells to pharmacologic concentrations (10-8 to 10-6M) of auranofin, 2,3,4,6,-tetra-O-acetyl-1-thio-β-D-glucopyranosato-S-triethylphosphine gold(I) (RidauraTM), a gold containing compound approved for the treatment of rheumatoid arthritis, results in the induction of several stress proteins. The enhanced synthesis of two polypeptides, p32 and p34, was particularly prominent. A similar response was observed in freshly collected human monocytes challenged with auranofin. In addition, oral administration of auranofin to rats induced enhanced synthesis of a 32-kDa protein in peritoneal exudate cells analyzed ex vivo at various times following drug treatment. These data suggest that increased synthesis of p32 and p34 might participate in mediating certain aspects of auranofin pharmacology.

UR - http://www.scopus.com/inward/record.url?scp=0022551580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022551580&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(86)80391-6

DO - 10.1016/S0006-291X(86)80391-6

M3 - Article

C2 - 3092816

AN - SCOPUS:0022551580

VL - 138

SP - 1074

EP - 1080

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -